PmcKwd.i
Checkpoint
Pmc
Racine
Checkpoint
Pmc
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Pmc)

Index « PmcKwd.i » - entrée « interleukin‐6 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
interleukin‐18 binding protein < interleukin‐6 < interlukin 6  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000563 (2019) Pietro Enea Lazzerini ; Franco Laghi-Pasini ; Maurizio Acampa ; Ujala Srivastava ; Iacopo Bertolozzi ; Beatrice Giabbani ; Francesco Finizola ; Francesca Vanni ; Aleksander Dokollari ; Mariarita Natale ; Gabriele Cevenini ; Enrico Selvi ; Nicola Migliacci ; Massimo Maccherini ; Mohamed Boutjdir ; Pier Leopoldo CapecchiSystemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin‐6–Mediated Changes in Connexin Expression
000813 (2019) Xintong Lyu ; Miao Zhang ; Guangqi Li ; Yiru Cai ; Guang Li ; Qiao QiaoInterleukin‐6 production mediated by the IRE1‐XBP1 pathway confers radioresistance in human papillomavirus‐negative oropharyngeal carcinoma
000814 (2019) Fredrik Anesten ; Adrià Dalmau Gasull ; Jennifer E. Richard ; Imre Farkas ; Devesh Mishra ; Lilly Taing ; Fuping Zhang ; Matti Poutanen ; Vilborg Palsdottir ; Zsolt Liposits ; Karolina P. Skibicka ; John-Olov JanssonInterleukin‐6 in the central amygdala is bioactive and co‐localised with glucagon‐like peptide‐1 receptor
000C23 (2018) A. Beringer ; N. Thiam ; J. Molle ; B. Bartosch ; P. MiossecSynergistic effect of interleukin‐17 and tumour necrosis factor‐α on inflammatory response in hepatocytes through interleukin‐6‐dependent and independent pathways
000D92 (2017) Yosuke Ohno ; Yujiro Toyoshima ; Hideaki Yurino ; Norikazu Monma ; Huihui Xiang ; Kentaro Sumida ; Shun Kaneumi ; Satoshi Terada ; Shinichi Hashimoto ; Kazuho Ikeo ; Shigenori Homma ; Hideki Kawamura ; Norihiko Takahashi ; Akinobu Taketomi ; Hidemitsu KitamuraLack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapy
000D98 (2017) Claes Held ; Harvey D. White ; Ralph A. H. Stewart ; Andrzej Budaj ; Christopher P. Cannon ; Judith S. Hochman ; Wolfgang Koenig ; Agneta Siegbahn ; Philippe Gabriel Steg ; Joseph Soffer ; W. Douglas Weaver ; Ollie Östlund ; Lars WallentinInflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Pmc/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i -k "interleukin‐6" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i  \
                -Sk "interleukin‐6" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    indexItem
   |index=    PmcKwd.i
   |clé=    interleukin‐6
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021